Red Maple Trials

A Phase 2, randomized, double-blind, placebo-controlled study to investigate the safety and efficacy in reducing nasal allergen challenge provoked symptoms of treatment with DM-101PX in adults with birch pollen allergic rhinitis or rhinoconjunctivitis.

The overall purpose of the study is to evaluate the safety and tolerability of treatment with DM-101PX and its efficacy in reducing symptoms provoked by Nasal Allergen Challenge (NAC) with birch pollen extract in individuals with moderate to severe birch pollen-induced allergic rhinitis or rhinoconjunctivitis.

Please click on the link below if you are interested in the study:

Desentum_C1A05912_Pre-Screening — Red Maple Trials birch allergy, allergies

A dermatologic study is enrolling participants in Ottawa to discover new treatment to
improve chronic hives.

See if you may qualify for this trial.

https://www.redmapletrials.com/research/currentstudies/calm-csu